Costs | Base case | Reference |
---|---|---|
Cost algorithm per analysis (varied) | $40 | |
Treatment costs* | ||
Average costs IAT eligible | $11,728 | Lobotesis et al. [19], Berkhemer et al. [3], McMeekin et al. [15], Mulder et al. [24] |
Average costs non-IAT eligible | $1004 | |
Acute stroke costs (< 90 days) | Lobotesis et al. [19] | |
mRS 0 | $4350 | |
mRS 1 | $5117 | |
mRS 2 | $5885 | |
mRS 3 | $22,695 | |
mRS 4 | $30,704 | |
mRS 5 | $36,468 | |
mRS 6 (death) | $4603 | |
Long term stroke costs (annually) | Lobotesis et al. [19] | |
mRS 0 | $3936 | |
mRS 1 | $4631 | |
mRS 2 | $5325 | |
mRS 3 | $18,944 | |
mRS 4 | $25,631 | |
mRS 5 | $41,621 | |
Discount costs | 4% | Guideline for economic evaluations in healthcare [21] |